• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

清除循环活化血小板在真性红细胞增多症和原发性血小板增多症。

Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia.

机构信息

Unit of Autoimmunity and Vascular Inflammation, Division of Regenerative Medicine, Gene Therapy and Stem Cells, Istituto Scientifico San Raffaele and Universita Vita-Salute San Raffaele, Milan, Italy.

出版信息

Blood. 2011 Sep 22;118(12):3359-66. doi: 10.1182/blood-2011-02-337337. Epub 2011 Jun 24.

DOI:10.1182/blood-2011-02-337337
PMID:21705500
Abstract

Essential thrombocythemia (ET) and polycythemia vera (PV) are characterized by persistent platelet activation. The mechanisms involved in their clearance are poorly characterized. In the present study, we report that leukocytes were actively involved in platelet disposal in 51 patients with ET and 30 with PV, but not in 70 age- and sex-matched controls. The fraction of circulating neutrophils and monocytes that had phagocytosed platelets, as assessed by flow cytometry, was significantly higher in patients with PV or ET, independently of hydroxyurea treatment, than in controls. Platelet phagocytosis by circulating leukocytes was confirmed by confocal and electron microscopy. The lack of effect of hydroxyurea, which disrupts the P-selectin/P-selectin glycoprotein ligand 1 (PSGL-1) interaction, suggests a P-selectin-independent mechanism. This hypothesis was confirmed in an ad hoc animal model based on the in vivo injection of activated platelets from P-selectin(+/+) and P-selectin(-/-) mice. P-selectin expression was associated with an earlier and effective clearance of platelets by neutrophils. A second delayed, P-selectin-independent phase actively involved monocytes. Our results suggest that phagocytic clearance of platelets by leukocytes occurs in PV and ET, possibly involving P-selectin-dependent and -independent pathways, thus representing a novel mechanism to remove activated platelets from the circulation.

摘要

特发性血小板增多症 (ET) 和真性红细胞增多症 (PV) 的特征是血小板持续活化。其清除机制尚未完全阐明。本研究报告称,在 51 例 ET 患者和 30 例 PV 患者中,白细胞积极参与了血小板的清除,但在 70 名年龄和性别匹配的对照者中没有这种现象。通过流式细胞术评估,循环中性粒细胞和单核细胞中吞噬血小板的比例在 PV 或 ET 患者中明显高于对照组,且与羟基脲治疗无关。通过共聚焦和电子显微镜确认了循环白细胞对血小板的吞噬作用。由于羟基脲会破坏 P-选择素/P-选择素糖蛋白配体 1 (PSGL-1) 的相互作用,因此不会影响血小板的吞噬作用,这表明存在一种 P-选择素非依赖性机制。在基于从 P-选择素(+/+)和 P-选择素(-/-)小鼠体内注射激活血小板的专门动物模型中证实了这一假设。P-选择素的表达与中性粒细胞更早、更有效的血小板清除有关。第二个延迟的、P-选择素非依赖性阶段则积极涉及单核细胞。我们的研究结果表明,白细胞通过吞噬作用清除血小板发生在 PV 和 ET 中,可能涉及 P-选择素依赖性和非依赖性途径,因此代表了一种从循环中清除活化血小板的新机制。

相似文献

1
Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia.清除循环活化血小板在真性红细胞增多症和原发性血小板增多症。
Blood. 2011 Sep 22;118(12):3359-66. doi: 10.1182/blood-2011-02-337337. Epub 2011 Jun 24.
2
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.JAK2V617F 等位基因负担与真性红细胞增多症和原发性血小板增多症患者血栓机制的激活有关。
Int J Hematol. 2014 Jan;99(1):32-40. doi: 10.1007/s12185-013-1475-9. Epub 2013 Nov 26.
3
Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.校准的自动化血栓生成仪检测到血小板诱导的凝血酶生成在原发性血小板增多症和红细胞增多症患者中增加。
Am J Hematol. 2011 Apr;86(4):337-42. doi: 10.1002/ajh.21974.
4
Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera.Src 酪氨酸激酶的预先激活与原发性血小板增多症和真性红细胞增多症中的血小板高反应性有关。
Blood. 2010 Jan 21;115(3):667-76. doi: 10.1182/blood-2008-12-196535. Epub 2009 Nov 12.
5
Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program.中性粒细胞在体内吞噬活化血小板:一种磷脂酰丝氨酸、P-选择素和β2整合素依赖性的细胞清除程序。
Blood. 2009 May 21;113(21):5254-65. doi: 10.1182/blood-2008-09-180794. Epub 2009 Mar 4.
6
Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者的一氧化氮衍生物和可溶性血浆选择素。
Thromb Haemost. 2010 Jul;104(1):151-6. doi: 10.1160/TH09-09-0663. Epub 2010 Apr 29.
7
ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.特发性血小板增多症和原发性红细胞增多症中,ADP 诱导的血小板聚集和凝血酶生成增加。
Thromb Res. 2013 Jul;132(1):88-93. doi: 10.1016/j.thromres.2013.05.003. Epub 2013 Jun 2.
8
Imaging flow cytometry in the assessment of leukocyte-platelet aggregates.成像流式细胞术在评估白细胞 - 血小板聚集体中的应用
Methods. 2017 Jan 1;112:46-54. doi: 10.1016/j.ymeth.2016.10.002. Epub 2016 Oct 5.
9
Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins.血小板与单核细胞的结合通过上调β1和β2整合素的表达及功能来增强单核细胞的黏附特性。
J Leukoc Biol. 2006 Mar;79(3):499-507. doi: 10.1189/jlb.0605318. Epub 2006 Jan 13.
10
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.血小板活化与功能受损的悖论:血小板与血管性血友病因子的相互作用,以及原发性血小板增多症和真性红细胞增多症中血栓形成和出血表现的病因。
Semin Thromb Hemost. 2006 Sep;32(6):589-604. doi: 10.1055/s-2006-949664.

引用本文的文献

1
Platelets as drivers of immunothrombosis in rheumatic diseases.血小板作为风湿性疾病中免疫血栓形成的驱动因素。
Nat Rev Rheumatol. 2025 Jul 7. doi: 10.1038/s41584-025-01276-z.
2
C-Mannosyl tryptophan is a novel biomarker for thrombocytosis of myeloproliferative neoplasms.C-甘露糖基色氨酸是骨髓增生性肿瘤血小板增多症的新型生物标志物。
Sci Rep. 2024 Aug 14;14(1):18858. doi: 10.1038/s41598-024-69496-z.
3
analysis of anti-HPA-1a dependent platelet phagocytosis and its inhibition using a new whole blood phagocytosis assay (WHOPPA).采用新的全血吞噬检测法(WHOPPA)分析抗 HPA-1a 依赖性血小板吞噬作用及其抑制作用。
Front Immunol. 2023 Nov 21;14:1283704. doi: 10.3389/fimmu.2023.1283704. eCollection 2023.
4
Polymorphisms and Gene-Gene Interaction in AGER/IL6 Pathway Might Be Associated with Diabetic Ischemic Heart Disease.AGER/IL6通路中的多态性及基因-基因相互作用可能与糖尿病缺血性心脏病相关。
J Pers Med. 2022 Mar 4;12(3):392. doi: 10.3390/jpm12030392.
5
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19.在 COVID-19 中,由 SARS-CoV-2 引发的非传统依赖 CD147 的血小板激活。
J Thromb Haemost. 2022 Feb;20(2):434-448. doi: 10.1111/jth.15575. Epub 2021 Nov 16.
6
Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).中性粒细胞胞外诱捕网(NETs)参与疫苗诱导的血栓性血小板减少症(VITT)的科学前提。
J Leukoc Biol. 2022 Mar;111(3):725-734. doi: 10.1002/JLB.5COVR0621-320RR. Epub 2021 Sep 1.
7
New Perspectives on Polycythemia Vera: From Diagnosis to Therapy.真性红细胞增多症的新视角:从诊断到治疗。
Int J Mol Sci. 2020 Aug 13;21(16):5805. doi: 10.3390/ijms21165805.
8
Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.原发性血小板增多症:对血栓形成危险因素和预后的止血观点。
Mol Biol Rep. 2020 Jun;47(6):4767-4778. doi: 10.1007/s11033-020-05536-x. Epub 2020 May 30.
9
Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro.内皮细胞的吞噬作用可抑制特发性血小板增多症血小板的体外促凝活性。
J Thromb Haemost. 2020 Jan;18(1):222-233. doi: 10.1111/jth.14617. Epub 2019 Sep 10.
10
Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.慢病毒基因疗法纠正了威斯科特-奥尔德里奇综合征患者的血小板表型和功能。
J Allergy Clin Immunol. 2019 Sep;144(3):825-838. doi: 10.1016/j.jaci.2019.03.012. Epub 2019 Mar 27.